Patient Access Solutions, Inc./ US70324A2087 /
2024-03-13 6:56:28 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0000USD | - | 502,090 Turnover: .5021 |
-Bid Size: - | -Ask Size: - | 0.0000 | 0.0000 |
GlobeNewswire
11:30 AM
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing ...
GlobeNewswire
03-14
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire
03-13
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment...
GlobeNewswire
03-12
Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to ...
GlobeNewswire
03-12
SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement
GlobeNewswire
03-11
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
GlobeNewswire
03-11
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arse...
GlobeNewswire
03-11
ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System
GlobeNewswire
03-08
Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
GlobeNewswire
03-07
Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2...
GlobeNewswire
03-07
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
GlobeNewswire
03-06
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association fo...
GlobeNewswire
03-05
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate...
GlobeNewswire
03-05
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Ge...
GlobeNewswire
03-05
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
GlobeNewswire
03-04
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
GlobeNewswire
03-04
Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial
GlobeNewswire
03-04
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01